Sign inGet started

Marantz Jing L.

Insider CIK 1834528 · NTLA EVP, Chief Medical Officer · KRYS Chief Business Officer, Director · SRRK Chief Medical Officer · ARCT Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
NTLA Intellia Therapeutics, Inc A Award deriv2026-10-262026-10-28275,061— $0275,061SEC↗
NTLA Intellia Therapeutics, Inc A Award2026-10-262026-10-28199,822— $0199,822SEC↗
ARCT Arcturus Therapeutics Hold A Award deriv2026-06-052026-06-1515,000— $015,000SEC↗
SRRK Scholar Rock Holding Corp S Sale2026-02-172026-02-194,157$46.53 $193.4K126,012SEC↗
SRRK Scholar Rock Holding Corp A Award2026-02-092026-02-1134,482— $0130,169SEC↗
SRRK Scholar Rock Holding Corp S Sale2026-01-162026-01-215,798$44.48 $257.9K95,687SEC↗
ARCT Arcturus Therapeutics Hold A Award deriv2025-06-092025-06-1115,000— $015,000SEC↗
SRRK Scholar Rock Holding Corp A Award deriv2025-03-102025-03-1245,715— $045,715SEC↗
SRRK Scholar Rock Holding Corp A Award2025-03-102025-03-1234,285— $0101,485SEC↗
SRRK Scholar Rock Holding Corp S Sale2025-01-162025-01-215,655$44.20 $250.0K67,200SEC↗
SRRK Scholar Rock Holding Corp M Exercise deriv2024-11-252024-11-266,375— $0130,000SEC↗
SRRK Scholar Rock Holding Corp M Exercise2024-11-252024-11-266,375$8.59 $54.8K79,230SEC↗
SRRK Scholar Rock Holding Corp S Sale2024-11-252024-11-261,000$38.04 $38.0K78,230SEC↗
SRRK Scholar Rock Holding Corp S Sale2024-11-252024-11-262,100$39.25 $82.4K76,130SEC↗
SRRK Scholar Rock Holding Corp S Sale2024-11-252024-11-263,075$39.93 $122.8K73,055SEC↗
SRRK Scholar Rock Holding Corp S Sale2024-11-252024-11-26200$40.72 $8.1K72,855SEC↗
SRRK Scholar Rock Holding Corp M Exercise deriv2024-11-222024-11-262,145— $0136,375SEC↗
SRRK Scholar Rock Holding Corp S Sale2024-11-222024-11-262,145$30.01 $64.4K72,855SEC↗
SRRK Scholar Rock Holding Corp M Exercise2024-11-222024-11-262,145$8.59 $18.4K75,000SEC↗
SRRK Scholar Rock Holding Corp M Exercise deriv2024-11-112024-11-132,105— $0138,520SEC↗
SRRK Scholar Rock Holding Corp S Sale2024-11-112024-11-132,105$30.00 $63.1K72,855SEC↗
SRRK Scholar Rock Holding Corp M Exercise2024-11-112024-11-132,105$8.59 $18.1K74,960SEC↗
SRRK Scholar Rock Holding Corp M Exercise deriv2024-10-072024-10-07109,375— $0140,625SEC↗
SRRK Scholar Rock Holding Corp S Sale2024-10-072024-10-0739,375$30.06 $1.18M72,855SEC↗
SRRK Scholar Rock Holding Corp S Sale2024-10-072024-10-072,552$26.22 $66.9K112,230SEC↗
SRRK Scholar Rock Holding Corp M Exercise2024-10-072024-10-07109,375$8.59 $939.5K182,230SEC↗
SRRK Scholar Rock Holding Corp S Sale2024-10-072024-10-0767,448$25.59 $1.73M114,782SEC↗
ARCT Arcturus Therapeutics Hold A Award deriv2024-06-142024-06-1815,000— $015,000SEC↗
ARCT Arcturus Therapeutics Hold M Exercise deriv2024-06-142024-06-183,131— $00SEC↗
ARCT Arcturus Therapeutics Hold M Exercise2024-06-142024-06-183,131— $03,131SEC↗
SRRK Scholar Rock Holding Corp A Award deriv2024-02-122024-02-1397,145— $097,145SEC↗
SRRK Scholar Rock Holding Corp A Award2024-02-122024-02-1372,855— $072,855SEC↗
ARCT Arcturus Therapeutics Hold A Award deriv2023-08-012023-08-033,131— $03,131SEC↗
ARCT Arcturus Therapeutics Hold A Award deriv2023-08-012023-08-0311,869— $011,869SEC↗
SRRK Scholar Rock Holding Corp A Award deriv2022-11-142022-11-15250,000— $0250,000SEC↗
ARCT Arcturus Therapeutics Hold A Award deriv2022-06-232022-06-2715,000— $015,000SEC↗
KRYS Krystal Biotech, Inc. A Award deriv2022-01-312022-01-31205,000— $0205,000SEC↗
ARCT Arcturus Therapeutics Hold A Award deriv2021-12-072021-12-0920,000— $020,000SEC↗
ARCT Arcturus Therapeutics Hold A Award deriv2021-12-072021-12-096,699— $06,699SEC↗
KRYS Krystal Biotech, Inc. A Award deriv2021-06-302021-07-026,800— $06,800SEC↗
KRYS Krystal Biotech, Inc. A Award deriv2021-01-042021-01-0513,600— $013,600SEC↗